PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 130 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2016. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $2,081,000 | -42.7% | 67,799 | +25.3% | 0.00% | -50.0% |
| Q3 2016 | $3,629,000 | +776.6% | 54,120 | +289.2% | 0.00% | – |
| Q2 2016 | $414,000 | +18.6% | 13,906 | +17.0% | 0.00% | – |
| Q1 2016 | $349,000 | -62.6% | 11,882 | 0.0% | 0.00% | -100.0% |
| Q4 2015 | $932,000 | -64.2% | 11,882 | -65.6% | 0.00% | -66.7% |
| Q3 2015 | $2,605,000 | -81.9% | 34,574 | -72.0% | 0.00% | -80.0% |
| Q2 2015 | $14,393,000 | -64.5% | 123,277 | -28.2% | 0.02% | -63.4% |
| Q1 2015 | $40,514,000 | +2.0% | 171,589 | -18.2% | 0.04% | +2.5% |
| Q4 2014 | $39,714,000 | -28.0% | 209,825 | -9.3% | 0.04% | -27.3% |
| Q3 2014 | $55,169,000 | +189.0% | 231,246 | -20.1% | 0.06% | +205.6% |
| Q2 2014 | $19,092,000 | -39.8% | 289,260 | -5.1% | 0.02% | -41.9% |
| Q1 2014 | $31,737,000 | +82.6% | 304,755 | +81.5% | 0.03% | +82.4% |
| Q4 2013 | $17,384,000 | +6.3% | 167,915 | -44.9% | 0.02% | +6.2% |
| Q3 2013 | $16,347,000 | -35.2% | 304,641 | -46.4% | 0.02% | -38.5% |
| Q2 2013 | $25,239,000 | – | 568,840 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |